Serina Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-22.4M | $259.0K |
| FY2017 | — | $7.3M | $7.4M |
| FY2018 | — | $7.4M | $6.7M |
| FY2019 | — | $2.2M | $2.4M |
| FY2020 | — | $-5.1M | $527.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-22.4M | $259.0K |
| FY2017 | — | $7.3M | $7.4M |
| FY2018 | — | $7.4M | $6.7M |
| FY2019 | — | $2.2M | $2.4M |
| FY2020 | — | $-5.1M | $527.0K |